#MedicalMarijuana in the News: September 9

know-your-cannabis-infographicHere are popular medical marijuana headlines for the week ending September 9, 2016.

Cannabis’s Effect on Children’s Epilepsy Being Studied by University

Researchers at the University of Sydney will partner with Epilepsy Action Australia to examine if cannabis-based extracts are effective for treating childhood epilepsy. Medical is still illegal in Australia.

Illegal Patient Profiles: Chronic Pain

“The number one use for medical marijuana in the United States is for chronic pain. Opponents of medical cannabis say that ‘chronic pain’ is a cop-out that people use as an excuse to get some legal weed and get high.”

By the way, did you know that September is Pain Awareness Month? Follow #PAM16 on Twitter.

Pain Patients Are Flooding into Minnesota’s Medical Marijuana Program

Minnesota’s medical marijuana program is tightly controlled with high costs and low enrollment. Advocates are hoping that pain patients might turn the tide.

VA Data Gives Detailed Picture of Veterans Using Medical Marijuana

“A review of Veterans Affairs Canada data on medical marijuana users, obtained by The Canadian Press under the Access to Information Act, suggests the number of users has grown most dramatically in those parts of the country where marijuana shops and clubs cater to a local population of military veterans.”

Medical Marijuana Patients Face Long Drives, High Prices

I can relate.

“Patients who use medical marijuana in the state of Delaware say they still struggle to gain access to the drug legally and pay exorbitant prices when they do.”

Why Medical Marijuana Patients Can’t Buy Guns

Some are still talking about the no-guns ruling for those with state-issued medical cannabis carads.

“Though a growing number of states are legalizing it for medical or recreational use, marijuana remains illegal for any purpose under federal law, which considers the drug to have a high potential for abuse and no accepted medical use.”


One comment

Comments are closed.